期刊
EUROPEAN SPINE JOURNAL
卷 9, 期 -, 页码 S119-S125出版社
SPRINGER
DOI: 10.1007/PL00008317
关键词
bone morphogenetic protein; gene therapy; bone graft substitute; spine fusion
This review will summarize the major efforts currently underway to develop osteoinductive bone graft substitutes for minimally invasive spine fusions. The primary categories of substitute include purl fled bone growth factors, recombinant bone growth factors, and growth factors delivered by gene therapy approaches. Clinical trials are underway for the purified and recombinant bone growth factors and pre-clinical studies have yielded promising results for a variety of gene therapy techniques for generating bone.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据